Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-220661
Filing Date
2011-08-12
Accepted
2011-08-12 10:23:48
Documents
13
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 798879
2 PLAN CONVERTIBLE PROMISSORY NOTE dex101.htm EX-10.1 32379
3 STOCK PLEDGE AGREEMENT dex102.htm EX-10.2 64744
4 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 10096
5 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 10281
6 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 3092
7 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 2987
  Complete submission text file 0001193125-11-220661.txt   3706059

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT abpi-20110630.xml EX-101.INS 500751
9 XBRL TAXONOMY EXTENSION SCHEMA abpi-20110630.xsd EX-101.SCH 24176
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abpi-20110630_cal.xml EX-101.CAL 57185
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abpi-20110630_def.xml EX-101.DEF 17949
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE abpi-20110630_lab.xml EX-101.LAB 212899
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abpi-20110630_pre.xml EX-101.PRE 133897
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-51383 | Film No.: 111029606
SIC: 2834 Pharmaceutical Preparations